ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.2131
Delayed Data
As of Aug 16
 +0.003 / +1.43%
Today’s Change
0.17
Today|||52-Week Range
0.55
-32.56%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.21
Today’s open0.21
Day’s range0.21 - 0.22
Volume80,223
Average volume (3 months)450,919
Market cap$8.8M
Data as of 3:53pm ET, 08/16/2018

Growth & Valuation

Earnings growth (last year)+84.41%
Earnings growth (this year)+47.97%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio0.1
Price/Sales--
Price/Book1.89

Competitors

 Today’s
change
Today’s
% change
SGLBSigma Labs Inc+0.05+5.87%
YTENYield10 Bioscience I...0.000.00%
BASIBioanalytical System...+0.04+2.68%
OPGNOpGen Inc-0.01-0.28%
Data as of 4:00pm ET, 08/16/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Westlake Village, California

Forecasts